3.7.2025 | Marginum News
Marginum has initiated a strategic collaboration with Mediplast AB, a trusted leader in healthcare distribution. The partnership aims to strengthen the availability and accessibility of Marginum’s products in the Nordics.
Under the agreement, Mediplast will serve as the exclusive distributor of Marginum’s novel HIVEN® aspirate tissue monitoring technology in Nordic countries (Norway, Sweden, Denmark, and Finland). With a strong commitment to clinical excellence and innovation, Mediplast collaborates closely with healthcare providers to ensure that its products meet the highest standards of safety, functionality and performance.
“We are excited to join forces with Mediplast”, says Samu Lehtonen MD, CEO of Marginum. “Their extensive network, deep market knowledge and proven track record in medical device distribution make them an ideal partner as we expand our global footprint in delivering innovative solutions to healthcare providers and patients.”
The collaboration reflects a shared commitment to improving patient outcomes and surgical cost-effectiveness through novel medical technology and streamlined delivery channels. By leveraging Mediplast’s logistics infrastructure and strong customer relationships, Marginum aims to accelerate the adoption of the aspirate tissue monitoring surgical technique and the HIVEN® device by providing timely support to healthcare professionals.
“Partnering with Marginum aligns perfectly with our mission to bring the highest quality medical products to those who need them the most”, says Hans Wallén, Sales & Marketing Director of Mediplast. “We look forward to a successful collaboration that will benefit our customers and ultimately improve lives.”
The partnership will take effect immediately following EU MDR certification for HIVEN®.
Samu Lehtonen MD
CEO, Marginum Ltd
samu.lehtonen@marginum.com
+358 40 579 7890
Hans Wallén
Sales & Marketing Director, Mediplast AB
hans.wallen@mediplast.com
+46 70 234 94 90
Marginum Ltd is a Finnish medical technology company developing fluorescence-based tissue detection systems. Founded in 2020, the Company’s data-driven solutions enable safe and efficient monitoring of tumour tissues during cancer surgery without compromising pre-existing surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team collaborates closely with academic, clinical, and industrial experts to ensure the seamless clinical compatibility of its technological solutions. www.marginum.com
Mediplast AB, headquartered in Malmö, Sweden, is a leading provider of high-quality medical devices and consumables, serving healthcare professionals across the Nordic region and international markets. Founded in 1960, Mediplast specialises in developing, marketing, and distributing a broad portfolio of products in areas such as surgery, intensive care, ENT (ear, nose, and throat), wound care, and diagnostics. www.mediplast.com
Published in:
3.11.2025 | BUSINESS FINLAND
Marginum has been selected for the prestigious Young Innovative Companies (YIC) program, a recognition reserved for Finland’s most promising startups.
20.10.2025 | MARGINUM NEWS
Marginum has completed the HIVEN® usability assessment at the University of Illinois College of Medicine Surgical Innovation and Training Laboratory.
15.10.2025 | Marginum News
Thomy F.E., d.o.o., one of Slovenia’s leading distributors of advanced medical and surgical technologies, has formed a strategic partnership with Marginum.
3.10.2025 | Redacción Médica
MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.
25.9.2025 | BUSINESS WIRE
Marginum receives MDR certification and releases the first-of-a-kind HIVEN® device, bringing the technology to clinical use in the EU.
22.8.2025 | Talouselämä
Marginum raises €2.5M in Pre-Series A funding to expand HIVEN® into European markets and acquire U.S. FDA clearance.